SEHK:928

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Life Healthcare Group

Executive Summary

Life Healthcare Group Limited, an investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong.


Snowflake Analysis

Flawless balance sheet and fair value.

Share Price & News

How has Life Healthcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 928's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

0%

928

5.1%

HK Healthcare

4.1%

HK Market


1 Year Return

-3.3%

928

-27.5%

HK Healthcare

-5.2%

HK Market

Return vs Industry: 928 exceeded the Hong Kong Healthcare industry which returned -27.5% over the past year.

Return vs Market: 928 exceeded the Hong Kong Market which returned -5.2% over the past year.


Shareholder returns

928IndustryMarket
7 Day0%5.1%4.1%
30 Day-6.5%2.4%3.5%
90 Day-25.6%-9.7%-5.3%
1 Year-3.3%-3.3%-25.7%-27.5%-2.0%-5.2%
3 Year-87.7%-87.7%-44.3%-47.6%-0.4%-10.6%
5 Year-98.9%-99.0%-51.7%-55.9%-9.0%-23.3%

Price Volatility Vs. Market

How volatile is Life Healthcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Life Healthcare Group undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: 928 (HK$0.03) is trading below our estimate of fair value (HK$4.33)

Significantly Below Fair Value: 928 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: 928 is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: 928 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 928's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 928 is good value based on its PB Ratio (0.6x) compared to the HK Healthcare industry average (1.2x).


Next Steps

Future Growth

How is Life Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Life Healthcare Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Life Healthcare Group performed over the past 5 years?

-26.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 928 is currently unprofitable.

Growing Profit Margin: 928 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: 928 is unprofitable, and losses have increased over the past 5 years at a rate of -26% per year.

Accelerating Growth: Unable to compare 928's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 928 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7%).


Return on Equity

High ROE: 928 has a negative Return on Equity (-24.58%), as it is currently unprofitable.


Next Steps

Financial Health

How is Life Healthcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: 928's short term assets (HK$222.1M) exceed its short term liabilities (HK$14.7M).

Long Term Liabilities: 928's short term assets (HK$222.1M) exceed its long term liabilities (HK$2.2M).


Debt to Equity History and Analysis

Debt Level: 928 is debt free.

Reducing Debt: 928 had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable 928 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: 928 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 3.7% per year.


Next Steps

Dividend

What is Life Healthcare Group's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 928's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 928's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 928's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 928's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 928 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 928's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.4yrs

Average management tenure


CEO

Life Healthcare Group has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Wai Lun Man
Executive Director1.42yrsHK$29.00kno data
Yuk Lun Chung
GM of Money Lending Business & Company Secretary3.25yrsHK$21.00kno data
Xueping Xu
Executive Chairman0.58yrno datano data
Zhiying Yang
Executive Director0.42yrno datano data

1.4yrs

Average Tenure

52.5yo

Average Age

Experienced Management: 928's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Wai Lun Man
Executive Director1.42yrsHK$29.00kno data
Xueping Xu
Executive Chairman0.58yrno datano data
Zhiying Yang
Executive Director0.42yrno datano data
Chunlei Zheng
Independent Non-Executive Director5.5yrsHK$240.00kno data
Hua Shan
Non-Executive Director4.5yrsHK$2.62mno data
Xinghua Liu
Independent Non-Executive Director3.75yrsHK$240.00kno data
Chun Man Cheng
Independent Non-Executive Director1yrno datano data

1.4yrs

Average Tenure

50yo

Average Age

Experienced Board: 928's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Life Healthcare Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Life Healthcare Group Limited
  • Ticker: 928
  • Exchange: SEHK
  • Founded: 2001
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: HK$149.920m
  • Shares outstanding: 5.35b
  • Website: https://www.lifehealthcare.com

Number of Employees


Location

  • Life Healthcare Group Limited
  • Office A
  • 18th Floor
  • Wan Chai
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TAFF.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDApr 2002
928SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDApr 2002

Biography

Life Healthcare Group Limited, an investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong. The company operates through three segments: Healthcare Services Business, Money Lending Business, and Securities Trading and Investments Business, and Others. It offers a range of services and solutions for medical and health administration through its non-invasive tumor genetic testing technology. The company also engages in apparel retail; securities trading and investment; and money lending activities. In addition, it provides corporate administrative and healthcare services. The company was formerly known as Tack Fiori International Group Limited and changed its name to Life Healthcare Group Limited in June 2017. Life Healthcare Group Limited was incorporated in 2001 and is based in Wan Chai, Hong Kong. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/06/04 12:36
End of Day Share Price2020/06/04 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.